These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31237628)

  • 1. Characteristics and Scope of Training of Clinicians Participating in the US Direct-to-Consumer Marketplace for Unproven Stem Cell Interventions.
    Fu W; Smith C; Turner L; Fojtik J; Pacyna JE; Master Z
    JAMA; 2019 Jun; 321(24):2463-2464. PubMed ID: 31237628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2015 Class of Hospice and Palliative Medicine Fellows-From Training to Practice: Implications for HPM Workforce Supply.
    Lupu D; Salsberg E; Quigley L; Wu X
    J Pain Symptom Manage; 2017 May; 53(5):944-951. PubMed ID: 28189768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical informatics subspecialists: characterizing a novel evolving workforce.
    Desai S; Mostaghimi A; Nambudiri VE
    J Am Med Inform Assoc; 2020 Nov; 27(11):1711-1715. PubMed ID: 32951031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.
    Turner L
    Perspect Biol Med; 2018; 61(1):7-24. PubMed ID: 29805145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counting physicians: inconsistencies in a commonly used source for workforce analysis.
    Freed GL; Nahra TA; Wheeler JR;
    Acad Med; 2006 Sep; 81(9):847-52. PubMed ID: 16936499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialty changes made by young physicians from graduate training to practice.
    Bertram DA
    Med Care; 1993 Jun; 31(6):533-41. PubMed ID: 8502001
    [No Abstract]   [Full Text] [Related]  

  • 7. Managed health care. Implications for the physician workforce and medical education. Council on Graduate Medical Education.
    Rivo ML; Mays HL; Katzoff J; Kindig DA
    JAMA; 1995 Sep; 274(9):712-5. PubMed ID: 7650824
    [No Abstract]   [Full Text] [Related]  

  • 8. The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions.
    Ogbogu U; Du J; Koukio Y
    BMC Med Ethics; 2018 May; 19(1):32. PubMed ID: 29716594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the Institute of Medicine.
    Lohr KN; Vanselow NA; Detmer DE
    JAMA; 1996 Mar; 275(10):748. PubMed ID: 8598579
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry Responsibilities in Tackling Direct-to-Consumer Marketing of Unproven Stem Cell Treatments.
    Master Z; Fu W; Paciulli D; Sipp D
    Clin Pharmacol Ther; 2017 Aug; 102(2):177-179. PubMed ID: 28695633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-consumer marketing of stem cell interventions by Canadian businesses.
    Turner L
    Regen Med; 2018 Sep; 13(6):643-658. PubMed ID: 30255734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action.
    Caulfield T; Murdoch B
    BMC Med Ethics; 2019 Aug; 20(1):51. PubMed ID: 31383026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crowdfunding for Unproven Stem Cell-Based Interventions.
    Snyder J; Turner L; Crooks VA
    JAMA; 2018 May; 319(18):1935-1936. PubMed ID: 29801003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The numerology of graduate medical education reform.
    Krol D
    JAMA; 1994 May; 271(17):1369, 1373. PubMed ID: 8158827
    [No Abstract]   [Full Text] [Related]  

  • 15. ASCP Board of Certification Survey of Medical Laboratory Science Faculty.
    Brown K; Parker Fenn J; Fong K; Freeman V; Genzen J; Goodyear N; Lunz Houston M; Taff T; Tanabe P
    Lab Med; 2019 Oct; 50(4):e75-e81. PubMed ID: 31115465
    [No Abstract]   [Full Text] [Related]  

  • 16. Stem cell clinics: risk of proliferation.
    Sissung TM; Figg WD
    Lancet Oncol; 2020 Feb; 21(2):205-206. PubMed ID: 32007195
    [No Abstract]   [Full Text] [Related]  

  • 17. The direct-to-consumer market for stem cell-based interventions in Australia: exploring the experiences of patients.
    Waldby C; Hendl T; Kerridge I; Lipworth W; Lysaght T; Munsie M; Stewart C
    Regen Med; 2020 Jan; 15(1):1238-1249. PubMed ID: 32009513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixing the US physician shortage requires many more slots for resident physicians in training.
    Rockey PH
    MedGenMed; 2006 May; 8(2):52. PubMed ID: 16926791
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical specialty boards can help measure graduate medical education outcomes.
    Peterson LE; Carek P; Holmboe ES; Puffer JC; Warm EJ; Phillips RL
    Acad Med; 2014 Jun; 89(6):840-2. PubMed ID: 24871232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Stakes: Direct to Consumer Marketing of Unproven Stem Cell Treatments for Lung Disease.
    Glassberg MK; Csete IS; Toonkel RL
    Chest; 2018 Jun; 153(6):1294-1295. PubMed ID: 29884248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.